Standard Family Office’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-450
Closed -$41K – 222
2021
Q4
$41K Buy
+450
New +$53.8K 0.36% 61
2021
Q3
– Sell
-835
Closed -$139K – 474
2021
Q2
$139K Buy
835
+11
+1% +$1.78K 0.03% 183
2021
Q1
$150K Buy
824
+17
+2% +$3.94K 0.04% 154
2020
Q4
$161K Buy
+807
New +$164K 0.04% 140

Other funds holding TDOC

Standard Family Office's TDOC Position: Q1 2022 in Review

Standard Family Office sold out of Teladoc Health (TDOC) in Q1 2022, closing a stake of 450 shares — an estimated $41K sold.

Standard Family Office first reported a position in TDOC in Q4 2020 and held it in 4 quarters. The position peaked at $161K in Q4 2020. 680 funds tracked by Wall St. Rank hold TDOC as of Q1 2022.

  • Standard Family Office reported no remaining Teladoc Health position as of Q1 2022 after selling out during the quarter.
  • Standard Family Office sold 450 Teladoc Health shares in Q1 2022, an estimated $41K.
  • Standard Family Office first reported a position in Teladoc Health in Q4 2020 and held it in 4 quarters.
  • Standard Family Office's Teladoc Health position peaked at $161K in Q4 2020.
  • 680 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2022.

Based on Standard Family Office's 13F filing for Q1 2022, filed 16 May 2022.